IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.
Arcellx is a privately held development-stage company founded in 2015 and located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although our initial clinical focus is cancer therapy, we are committed to extending our Antigen- Receptor Complex T cell (ARC-T) therapies across a broad spectrum of human disease.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
Resilience, formally known as National Resilience, Inc., is a biopharmaceutical manufacturing and technology company established in 2020 and headquartered in La Jolla, California. The company specializes in end-to-end manufacturing and development solutions, focusing on advanced manufacturing technologies for various therapeutic modalities, including cell and gene therapies, viral vectors, vaccines, and proteins. Resilience is committed to expanding access to complex medicines and ensuring the stability of biopharmaceutical supply chains against potential disruptions. Through its innovative approaches, the company aims to enhance the efficiency and security of biopharmaceutical production, ultimately contributing to improved healthcare outcomes.
ZeroFox is a cybersecurity company based in Baltimore, Maryland, that specializes in protecting organizations from threats arising from social networking and digital communication platforms. The company offers a range of solutions, including real-time social threat analytics, intelligence, and advanced security protection through its cloud-based platform. Its products, such as the ZeroFOX intelligence Livefeed and Protection Cloud, help organizations proactively defend against malware, targeted attacks, and various forms of social engineering, including impersonation and fraud. Additionally, ZeroFox provides services aimed at safeguarding high-value employees and political candidates from targeted threats. The company serves diverse industries, including financial services, healthcare, and technology, by continuously monitoring social media for cyber attacks and information loss. Founded in 2013, ZeroFox has received multiple industry accolades for its innovative approach to cybersecurity.
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.
Arcellx is a privately held development-stage company founded in 2015 and located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although our initial clinical focus is cancer therapy, we are committed to extending our Antigen- Receptor Complex T cell (ARC-T) therapies across a broad spectrum of human disease.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in continuous glucose monitoring (CGM) systems for individuals with diabetes, primarily in Europe. Founded in 1996, the company develops advanced implantable CGM products, including Eversense and Eversense XL, which monitor glucose levels for up to 90 and 180 days, respectively. Using innovative fluorescence sensing technology, these systems are designed to provide high accuracy and stability throughout their extended sensor life. The company aims to empower people with diabetes to manage their condition more effectively and confidently through its CGM solutions, which also include a smart transmitter and a mobile app. A significant portion of Senseonics' revenue is generated from markets outside the United States.
Blispay Inc. is a financial technology company based in Baltimore, Maryland, that specializes in providing mobile payment solutions and point-of-sale financing for small and midsize retailers. Founded in 2014, Blispay offers a mobile-centric credit card that allows merchants to provide financing options to their customers without the need for technical integration or financial obligations. The Blispay Visa Card features instant issuance, six months of special financing, and a cash-back incentive, making it an attractive option for both retailers and consumers. The company's founding team includes industry veterans with backgrounds from notable organizations, enhancing its capability to deliver innovative financial products that meet the needs of modern shoppers and merchants alike.
Fugue, Inc. is a company that specializes in cloud infrastructure automation and security software. Founded in 2012 and based in Frederick, Maryland, Fugue develops an operating system designed for managing cloud-based workloads. The company's solutions focus on ensuring continuous compliance with enterprise security policies by identifying and addressing security risks and compliance violations. Fugue's software features capabilities such as baseline drift detection, automated remediation, and powerful visualization and reporting tools, which help organizations demonstrate compliance with various frameworks, including HIPAA, GDPR, and NIST 800-53. It integrates with CI/CD pipelines to prevent unauthorized changes and automate compliance audits. Notable clients include Sparkpost, PBS, and SAP NS2, who rely on Fugue to mitigate cloud risks and enforce compliance effectively.
Vtesse, Inc. develops drugs for patients suffering from rare diseases. The company focuses on conducting the clinical study of VTS-270 for the treatment of Niemann-Pick disease type C (NPC), as well as on conducting pre-clinical discovery and development of other novel drugs for NPC and other lysosomal storage diseases. Vtesse, Inc. is based in Gaithersburg, Maryland. As of April 3, 2017, Vtesse, Inc. operates as a subsidiary of Sucampo Pharmaceuticals, Inc.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Blispay Inc. is a financial technology company based in Baltimore, Maryland, that specializes in providing mobile payment solutions and point-of-sale financing for small and midsize retailers. Founded in 2014, Blispay offers a mobile-centric credit card that allows merchants to provide financing options to their customers without the need for technical integration or financial obligations. The Blispay Visa Card features instant issuance, six months of special financing, and a cash-back incentive, making it an attractive option for both retailers and consumers. The company's founding team includes industry veterans with backgrounds from notable organizations, enhancing its capability to deliver innovative financial products that meet the needs of modern shoppers and merchants alike.
Fugue, Inc. is a company that specializes in cloud infrastructure automation and security software. Founded in 2012 and based in Frederick, Maryland, Fugue develops an operating system designed for managing cloud-based workloads. The company's solutions focus on ensuring continuous compliance with enterprise security policies by identifying and addressing security risks and compliance violations. Fugue's software features capabilities such as baseline drift detection, automated remediation, and powerful visualization and reporting tools, which help organizations demonstrate compliance with various frameworks, including HIPAA, GDPR, and NIST 800-53. It integrates with CI/CD pipelines to prevent unauthorized changes and automate compliance audits. Notable clients include Sparkpost, PBS, and SAP NS2, who rely on Fugue to mitigate cloud risks and enforce compliance effectively.
ZeroFox is a cybersecurity company based in Baltimore, Maryland, that specializes in protecting organizations from threats arising from social networking and digital communication platforms. The company offers a range of solutions, including real-time social threat analytics, intelligence, and advanced security protection through its cloud-based platform. Its products, such as the ZeroFOX intelligence Livefeed and Protection Cloud, help organizations proactively defend against malware, targeted attacks, and various forms of social engineering, including impersonation and fraud. Additionally, ZeroFox provides services aimed at safeguarding high-value employees and political candidates from targeted threats. The company serves diverse industries, including financial services, healthcare, and technology, by continuously monitoring social media for cyber attacks and information loss. Founded in 2013, ZeroFox has received multiple industry accolades for its innovative approach to cybersecurity.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Vtesse, Inc. develops drugs for patients suffering from rare diseases. The company focuses on conducting the clinical study of VTS-270 for the treatment of Niemann-Pick disease type C (NPC), as well as on conducting pre-clinical discovery and development of other novel drugs for NPC and other lysosomal storage diseases. Vtesse, Inc. is based in Gaithersburg, Maryland. As of April 3, 2017, Vtesse, Inc. operates as a subsidiary of Sucampo Pharmaceuticals, Inc.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Fugue, Inc. is a company that specializes in cloud infrastructure automation and security software. Founded in 2012 and based in Frederick, Maryland, Fugue develops an operating system designed for managing cloud-based workloads. The company's solutions focus on ensuring continuous compliance with enterprise security policies by identifying and addressing security risks and compliance violations. Fugue's software features capabilities such as baseline drift detection, automated remediation, and powerful visualization and reporting tools, which help organizations demonstrate compliance with various frameworks, including HIPAA, GDPR, and NIST 800-53. It integrates with CI/CD pipelines to prevent unauthorized changes and automate compliance audits. Notable clients include Sparkpost, PBS, and SAP NS2, who rely on Fugue to mitigate cloud risks and enforce compliance effectively.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases, with a particular focus on inherited metabolic disorders. The company's pipeline includes therapies such as CERC-801, CERC-802, and CERC-803, which have completed phase I clinical trials. Additionally, Cerecor is developing CERC-007, an anti-IL-18 monoclonal antibody for autoimmune inflammatory diseases, and CERC-006, a dual mTOR inhibitor for complex lymphatic malformations. Other notable developments include CERC-002 for pediatric-onset Crohn's disease, CERC-913 for mitochondrial disorders, and CERC-005 for rare auto-inflammatory diseases. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions. Founded in 2011 and headquartered in Rockville, Maryland, the company was previously known as Ceregen Corporation before rebranding in March 2011.
NexImmune, Inc., a biopharmaceutical company, develops novel immuno-therapeutics based on the proprietary Artificial IMmune (AIMTM) technology. It offers AIM101, an aAPC-based injectable pharmaceutical product for the treatment of specific solid tumors; and AIM ACT, an adoptive cellular therapy to treat specific hematological malignancies. Its products are used to treat cancer, inflammation, viral diseases, transplant rejection, autoimmunity, and more. The company was founded in 2011 and is based in Gaithersburg, Maryland.
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in continuous glucose monitoring (CGM) systems for individuals with diabetes, primarily in Europe. Founded in 1996, the company develops advanced implantable CGM products, including Eversense and Eversense XL, which monitor glucose levels for up to 90 and 180 days, respectively. Using innovative fluorescence sensing technology, these systems are designed to provide high accuracy and stability throughout their extended sensor life. The company aims to empower people with diabetes to manage their condition more effectively and confidently through its CGM solutions, which also include a smart transmitter and a mobile app. A significant portion of Senseonics' revenue is generated from markets outside the United States.
ZeroFox is a cybersecurity company based in Baltimore, Maryland, that specializes in protecting organizations from threats arising from social networking and digital communication platforms. The company offers a range of solutions, including real-time social threat analytics, intelligence, and advanced security protection through its cloud-based platform. Its products, such as the ZeroFOX intelligence Livefeed and Protection Cloud, help organizations proactively defend against malware, targeted attacks, and various forms of social engineering, including impersonation and fraud. Additionally, ZeroFox provides services aimed at safeguarding high-value employees and political candidates from targeted threats. The company serves diverse industries, including financial services, healthcare, and technology, by continuously monitoring social media for cyber attacks and information loss. Founded in 2013, ZeroFox has received multiple industry accolades for its innovative approach to cybersecurity.
Videology is a digital media advertising technology solutions provider, providing its clients with solutions to connect advertiser brands with consumers who are most interested in those brands. By leveraging the power of consumer data and ad decisioning, we increase accountability, and optimize the performance of video and display advertising campaigns by providing a more relevant, meaningful web experience for consumers who view the ads delivered through our advertising technology solutions.
Traitify is a personality data company building the personality data genome for the employment marketplace. The company uses human interaction with images to create the fastest validated talent assessments in the market. Its platform includes the fastest talent assessments in the world multiple image-based behavioral assessments that are scientifically-validated and take 90 seconds to 2 minutes to complete on a mobile device and have 95% or greater completion rates. Companies use their platform to create a great candidate and employee experiences. Imagine giving value back to the candidates in the talent pool by making personalized recommendations for what job to apply for. Or generating personalized content to share back with candidates to create ongoing engagement, all based on their unique personality traits. Companies with great employment brands create reciprocity with candidates and employees alike.
Bravo Health, Inc. provides managed care services. It offers Medicare advantage options to allow members to choose the right plan for them; and special needs plans for those who are receiving institutional care, who have chronic health conditions, or who are eligible for both Medicare and Medicaid benefits. The company also provides private fee-for-service plans, which provide members the freedom to determine from whom they receive their health care; and part D prescription plans for those who only need coverage for their medications. It offers its plans to members in Delaware, Maryland, Pennsylvania, Texas, Washington, D.C., California, Florida, Illinois, Michigan, New Jersey, New York, Ohio, and West Virginia. Bravo Health, Inc. was formerly known as Elder Health, Inc. The company was founded in 1996 and is based in Baltimore, Maryland.
Sonatype, Inc. specializes in software supply chain automation solutions aimed at enhancing the security and efficiency of software development. The company's flagship product, Nexus Lifecycle, enables organizations to manage the flow of software components by defining rules and policies. Additionally, Nexus Firewall protects against the introduction of risky components, while Nexus Auditor monitors applications in production to ensure ongoing compliance. The Nexus Repository serves as a platform for organizing, storing, and distributing software components, and Nexus Repository OSS facilitates caching of remote repositories to reduce latency. Sonatype caters to various industries, including finance, government, technology, insurance, healthcare, and manufacturing, and has established a strategic partnership with Fugue. Founded in 2008 and headquartered in Fulton, Maryland, Sonatype also maintains offices in McLean, Virginia; London, United Kingdom; and Sydney, Australia. The company's commitment to open source software development is evident in its contributions to projects like Apache Maven and the Central repository.
Videology is a digital media advertising technology solutions provider, providing its clients with solutions to connect advertiser brands with consumers who are most interested in those brands. By leveraging the power of consumer data and ad decisioning, we increase accountability, and optimize the performance of video and display advertising campaigns by providing a more relevant, meaningful web experience for consumers who view the ads delivered through our advertising technology solutions.
Millennial Media Inc. specializes in mobile advertising solutions for advertisers and developers both in the United States and internationally. The company provides tools that allow advertisers to engage targeted audiences across various mobile devices, offering insights into campaign performance and management. Its offerings include a demand side platform that connects directly with developers through an advertising exchange, a premium mobile advertising exchange solution, and a design platform for creating advertisements. For developers, Millennial Media provides software development kits for various ad formats, ad serving capabilities, mediation tools, and analytics for tracking ad revenue across mobile operating systems. Additionally, the company operates MYDAS, a technology designed to identify unique users and deliver targeted ads based on user interests and behaviors. Founded in 2006 and headquartered in Baltimore, Maryland, Millennial Media has been acquired by AOL, enhancing its mobile capabilities and monetization potential for app developers and publishers.
Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of the next-generation of antibody-derived drugs. The company uses proprietary technology to enable the development of singular molecular entities that address two or more targets, by combining the activity of two or more biologic therapies into one protein (known as a Zybodyâ„¢). In addition, the technology will also be applied to drug targets that previously have not been reachable through the use of traditional, single specificity, monoclonal antibodies.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
Millennial Media Inc. specializes in mobile advertising solutions for advertisers and developers both in the United States and internationally. The company provides tools that allow advertisers to engage targeted audiences across various mobile devices, offering insights into campaign performance and management. Its offerings include a demand side platform that connects directly with developers through an advertising exchange, a premium mobile advertising exchange solution, and a design platform for creating advertisements. For developers, Millennial Media provides software development kits for various ad formats, ad serving capabilities, mediation tools, and analytics for tracking ad revenue across mobile operating systems. Additionally, the company operates MYDAS, a technology designed to identify unique users and deliver targeted ads based on user interests and behaviors. Founded in 2006 and headquartered in Baltimore, Maryland, Millennial Media has been acquired by AOL, enhancing its mobile capabilities and monetization potential for app developers and publishers.
Availink (中天联科) is a company focused on designing chips using semiconductors for digital TV and multimedia areas, and developing application systems. Its product line extends to every specified market ranging from satellite television demodulator chips, to the fields of digital TV. The satellite television demodulator chip, covers all digital television technology standards such as satellites, ground surfaces, and wired. Availink provides many kinds of demodulation and decoding chips. The chip-based system platform schemes and multimedia solutions can mainly be applied to the rapidly developing digital TV field while providing products and services for global enterprise clients. Established in 2005, Availink was founded by a team of scientists. Currently It has a professional core management team with years of R&D experience. Availinks' accumulated chips shipped more than one hundred million pieces.
Optinuity, Inc. provides autonomic policy management solutions to enterprises and service providers. Its solutions include Optinuity Oasis, which provides software for creating and implementing autonomic policies to make complex business systems self-managed. The company also provides professional services, including autonomic policy planning and design, installation and configuration, and custom development services; and training services. It primarily offers its solutions for financial services, health care, and telecommunications sectors. Optinuity, Inc. was founded in 2004 and is headquartered in Bethesda, Maryland. As of October 6, 2008, Optinuity, Inc. operates as a subsidiary of CA, Inc.
Videology is a digital media advertising technology solutions provider, providing its clients with solutions to connect advertiser brands with consumers who are most interested in those brands. By leveraging the power of consumer data and ad decisioning, we increase accountability, and optimize the performance of video and display advertising campaigns by providing a more relevant, meaningful web experience for consumers who view the ads delivered through our advertising technology solutions.
Hillcrest Laboratories is a leading global supplier of motion processing solutions. These solutions use MEMS sensors to capture human and mechanical movement, translating that into motion patters which can be used to control and interact with devices. This motion technology is then used to enhance products in both consumer technology and industrial fields.
The company is widely recognized as a leader in the Smart TV industry, having created HoME, the first pointer-based interactive media system for TV, and the award winning Loop remote control. Today it counts LG, Roku and TCL among its Smart TV customers. Building on these roots in Smart TV, the company has expanded focus and now has customers in the smartphone and mobile device industry, licenses technology to leading gaming systems and provides solutions to virtual reality customers.
Hillcrest Labs has received numerous awards including the CES Innovations Award in 2006, 2010, 2011 and 2012, PC World's 100 Best Products and Greatest Tech Designs, Popular Mechanics' Editors Choice, ECN's Reader's Choice Tech, and many others. Based in Rockville, Maryland, Hillcrest Labs was founded in 2001 by Dan Simpkins. The company is funded by NEA, Columbia Capital and Grotech Capital.
Optinuity, Inc. provides autonomic policy management solutions to enterprises and service providers. Its solutions include Optinuity Oasis, which provides software for creating and implementing autonomic policies to make complex business systems self-managed. The company also provides professional services, including autonomic policy planning and design, installation and configuration, and custom development services; and training services. It primarily offers its solutions for financial services, health care, and telecommunications sectors. Optinuity, Inc. was founded in 2004 and is headquartered in Bethesda, Maryland. As of October 6, 2008, Optinuity, Inc. operates as a subsidiary of CA, Inc.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. The company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
Sourcefire, Inc. specializes in enterprise threat management solutions for a variety of sectors, including healthcare, finance, manufacturing, energy, education, retail, telecommunications, and government organizations. The company is known for its open source and commercial security products, most notably Snort, which is an open source intrusion prevention technology integral to the Sourcefire 3D System. This system offers a comprehensive approach to network defense, combining intrusion prevention, network behavior analysis, access control, and vulnerability assessment within a unified management framework. Additionally, Sourcefire provides ClamAV, an open source gateway anti-virus and anti-malware solution. The company offers various technical support and professional services, including deployment assistance, customer support, and education. Sourcefire markets its products and services through both direct sales and partnerships with resellers, distributors, and original equipment manufacturers. Founded in 2001, Sourcefire is headquartered in Columbia, Maryland.
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsidiary of Shire plc and, upon its acquisition of substantially all the assets of Shire Laboratories Inc. in late 2005, as Supernus Pharmaceuticals. The company is developing several product candidates in neurology and psychiatry to address large market opportunities in epilepsy, ADHD and depression. In addition to its two ADHD product candidates, Supernus is developing two late stage epilepsy product candidates, SPN-538 (extended release topiramate), and Epliga® (extended release oxcarbazepine).
Availink (中天联科) is a company focused on designing chips using semiconductors for digital TV and multimedia areas, and developing application systems. Its product line extends to every specified market ranging from satellite television demodulator chips, to the fields of digital TV. The satellite television demodulator chip, covers all digital television technology standards such as satellites, ground surfaces, and wired. Availink provides many kinds of demodulation and decoding chips. The chip-based system platform schemes and multimedia solutions can mainly be applied to the rapidly developing digital TV field while providing products and services for global enterprise clients. Established in 2005, Availink was founded by a team of scientists. Currently It has a professional core management team with years of R&D experience. Availinks' accumulated chips shipped more than one hundred million pieces.
eNeura Inc. is a medical technology company focused on developing portable, non-invasive transcranial magnetic stimulation (TMS) devices for the treatment and prevention of migraines. Its flagship product, the sTMS mini, utilizes single-pulse TMS to provide migraine relief by generating targeted magnetic fields that pass through bone and tissue. This device is designed for both acute and prophylactic treatment of migraines in adolescents aged 12 and older, as well as adults, allowing for convenient use at home or on the go. eNeura was established in 2012 and is headquartered in San Jose, California, with an additional office in Baltimore, Maryland. The company, formerly known as eNeura Therapeutics LLC, rebranded in February 2014. However, it faced financial difficulties and filed for liquidation under Chapter 7 in August 2020.
Availink (中天联科) is a company focused on designing chips using semiconductors for digital TV and multimedia areas, and developing application systems. Its product line extends to every specified market ranging from satellite television demodulator chips, to the fields of digital TV. The satellite television demodulator chip, covers all digital television technology standards such as satellites, ground surfaces, and wired. Availink provides many kinds of demodulation and decoding chips. The chip-based system platform schemes and multimedia solutions can mainly be applied to the rapidly developing digital TV field while providing products and services for global enterprise clients. Established in 2005, Availink was founded by a team of scientists. Currently It has a professional core management team with years of R&D experience. Availinks' accumulated chips shipped more than one hundred million pieces.
Optinuity, Inc. provides autonomic policy management solutions to enterprises and service providers. Its solutions include Optinuity Oasis, which provides software for creating and implementing autonomic policies to make complex business systems self-managed. The company also provides professional services, including autonomic policy planning and design, installation and configuration, and custom development services; and training services. It primarily offers its solutions for financial services, health care, and telecommunications sectors. Optinuity, Inc. was founded in 2004 and is headquartered in Bethesda, Maryland. As of October 6, 2008, Optinuity, Inc. operates as a subsidiary of CA, Inc.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
Psyadon Pharmaceuticals, Inc. engages in the discovery and development of drugs for psychiatric and neurological diseases. The company develops Ecopipam, a neurotransmitter dopamine at the D1 subtype in the brain. Psyadon Pharmaceuticals, Inc. was formerly known as Ruxton Pharmaceuticals, Inc. and changed its name to Psyadon Pharmaceuticals, Inc. in October 2008. The company was founded in 2004 and is based in Germantown, Maryland. As of August 14, 2018, Psyadon Pharmaceuticals, Inc. operates as a subsidiary of Emalex Biosciences, Inc.
Sourcefire, Inc. specializes in enterprise threat management solutions for a variety of sectors, including healthcare, finance, manufacturing, energy, education, retail, telecommunications, and government organizations. The company is known for its open source and commercial security products, most notably Snort, which is an open source intrusion prevention technology integral to the Sourcefire 3D System. This system offers a comprehensive approach to network defense, combining intrusion prevention, network behavior analysis, access control, and vulnerability assessment within a unified management framework. Additionally, Sourcefire provides ClamAV, an open source gateway anti-virus and anti-malware solution. The company offers various technical support and professional services, including deployment assistance, customer support, and education. Sourcefire markets its products and services through both direct sales and partnerships with resellers, distributors, and original equipment manufacturers. Founded in 2001, Sourcefire is headquartered in Columbia, Maryland.
Hillcrest Laboratories is a leading global supplier of motion processing solutions. These solutions use MEMS sensors to capture human and mechanical movement, translating that into motion patters which can be used to control and interact with devices. This motion technology is then used to enhance products in both consumer technology and industrial fields.
The company is widely recognized as a leader in the Smart TV industry, having created HoME, the first pointer-based interactive media system for TV, and the award winning Loop remote control. Today it counts LG, Roku and TCL among its Smart TV customers. Building on these roots in Smart TV, the company has expanded focus and now has customers in the smartphone and mobile device industry, licenses technology to leading gaming systems and provides solutions to virtual reality customers.
Hillcrest Labs has received numerous awards including the CES Innovations Award in 2006, 2010, 2011 and 2012, PC World's 100 Best Products and Greatest Tech Designs, Popular Mechanics' Editors Choice, ECN's Reader's Choice Tech, and many others. Based in Rockville, Maryland, Hillcrest Labs was founded in 2001 by Dan Simpkins. The company is funded by NEA, Columbia Capital and Grotech Capital.
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
Covega Corporation has established world-class proprietary technologies in InP and LiNbO3 to produce high performance optical devices and modules at a low cost with very small footprints. With early focus on the telecom, datacom and CATV industries, Covega now generates over one-third of its revenue from serving the defense, medical, industrial and instrumentation industries.
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.
eNeura Inc. is a medical technology company focused on developing portable, non-invasive transcranial magnetic stimulation (TMS) devices for the treatment and prevention of migraines. Its flagship product, the sTMS mini, utilizes single-pulse TMS to provide migraine relief by generating targeted magnetic fields that pass through bone and tissue. This device is designed for both acute and prophylactic treatment of migraines in adolescents aged 12 and older, as well as adults, allowing for convenient use at home or on the go. eNeura was established in 2012 and is headquartered in San Jose, California, with an additional office in Baltimore, Maryland. The company, formerly known as eNeura Therapeutics LLC, rebranded in February 2014. However, it faced financial difficulties and filed for liquidation under Chapter 7 in August 2020.
Megisto develops hardware it sells to telecom companies, which is used to connect mobile wireless subscribers to different data services.
CODEON
Venture Round in 2000
CODEON Corporation designs and manufactures state-of-the-art optical components for the fiber optic telecommunications industry.
YAFO Networks designs, manufacturers and markets optical-electrical hardware subsystems for fiber optic networks. YAFO’s goal is clear - provide high quality, cutting-edge photonic network sub-system level solutions. By employing the highest caliber of talent in the fiber optics and communications industries, They specialize in Their ability to identify and target key optical transport problems, and incorporate the technologies that best solve these problems. This provides YAFO’s customers with the advantage of having access to the highest quality of optical communication solutions with fastest time to market. YAFO’s innovative solutions drive down the equipment cost of transporting data while greatly enhancing the quality of bit.
AMISYS Managed Care Systems, Inc. develops, markets and supports managed health care information systems and software.
Bethesda Research Laboratories
Venture Round in 1982
Bethesda Research Laboratories is a developer and distributor of enzymes and other products allowing manipulation of DNA.